Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Inhibitory Effect of Gamihwalhyeol-tang on Inflammatory Cytokine and NF-kB, AP-1 Activation in Human Synovial Cells

가미활혈탕이 Rheumatoid arthritis 관련 싸이토카인 및 전사인자에 미치는 영향

  • Shin Sang Moon (Department of Oriental Medicine, Daejeon University) ;
  • Park Jong Ho (Department of Oriental Medicine, Daejeon University) ;
  • Yoo Dong Youl (Department of Oriental Medicine, Daejeon University) ;
  • Kim Dong Hee (Department of Oriental Medicine, Daejeon University)
  • Published : 2003.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

The present study was carried out to examine the effects of Kami-hwal-hyeol-tang(KHHT) on the immune responses of synoviocyte cells prepared from the rheumatoid arthritis patients, and also on the collagen-mediated arthritis in mouse model. Several experiments were performed in vitro and in vivo to analyse the immunomodulatory effects of KHHT, and the major findings are summarized below: 1. KHHT did not show the cytotoxicity against mLFCs and hFLSs. 2. KHHT inhibited gene expression of IL-1β, IL-6, TNF-α, COX-2, NOS and GM-CSF in hFLSs. Furthermore, KHHT-treated hFLSs showed reduced production of pro-inflammatory cytokines such as IL-1β and IL-6 compared to the control cells. 3. KHHT treatment of hFLSs inhibited the binding activity of NF-kB and AP-1 to their consensus DNA sequences. 4. KHHT treatment(400 ㎍/㎖) of hFLSs significantly inhibited hFLSs proliferations compared to the control cells. 5. KHHT significantly reduced the production of ROS in hFLSs compared to the control cells. The present data show that KHHT plays an important role for the regulation of AP-1 and NF-kB gene expression. Also, it was found that KHHT has anti-arthritis effect. Further studies of KHHT in relation to RA therapeutics may provide important information to develop drugs to treat this disease.

Keywords

References

  1. 整形外科學 大韓整形外科學會
  2. 무릎의 동통과 기능장애 무릎을 침해하는 여러 가지 관절염 Rene Cailliet. M. D.
  3. 의약정보 v.19 no.3 류마티스 관절염의 병태생리 김호연
  4. 면역학 서울대학교의과대학
  5. Clin Evid. no.7 Rheumatoid arthritis Emery P;Foster W;Suarez-Almazor M.
  6. Arthritis Res. v.4 no.Suppl 3 Studies of T-cell activation in chronic inflammation Cope AP https://doi.org/10.1186/ar557
  7. 今釋黃帝內經素問 裵秉哲(譯)
  8. 痺證, 鼎談 權宰植(外 4人)
  9. 診療要鑑 金定濟
  10. 增補韓方臨床40年 朴柄昆
  11. J Rheumatol Suppl. v.65 Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis? Dayer JM.
  12. J Rheumatol Suppl. no.65 The mode of action of cytokine inhibitors. Arend WP.
  13. J Rheumatol Suppl. v.65 Preventing joint damage as the best measure of biologic drug therapy. Bresnihan B.
  14. Curr Gene Ther. v.2 no.3 Gene therapy strategies to prevent autoimmune disorders. Trucco M;Robbins PD;Thomson AW;Giannoukakis N. https://doi.org/10.2174/1566523023347760
  15. Hum Gene Ther. v.13 no.10 Tetracycline-inducible interleukin-10 gene transferrmediated by an adeno-associated virus: application to experimental arthritis. Apparailly F;Millet V;Noel D;Jacquet C;Sany J;Jorgensen C. https://doi.org/10.1089/104303402320138961
  16. 骨, 關節疾患 金寅相(譯)
  17. 竝祛湯이 류마토이드 關節炎 및 Human Monocyte의 IL-8에 미치는 影響 李忠遠
  18. 桂枝芍藥知母湯이 第ll型 Collagen 誘發 關節炎의 抗體에 미치는 影響 申炳熙
  19. 白虎湯과 白虎加桂枝湯이 류마토이드 關節炎 및human Monocyte의 IL-8에 미치는 影響 柳京周
  20. 澤蘭 藥鍼이 collagen으로 유발시킨 關節炎에 미치는 影響 李俊昊　
  21. 虎杖根과 虎杖根에서 分離한 Resveratrol과Ｅmodin이 류마토이드 關節炎 抑制에 미치는 影響 염익환　
  22. 한방병원처방집　 대전대학교 한방병원
  23. 新中醫　 v.21 no.11 辨證治療痺證（類風濕性關節炎爲主）480例的臨床總結　 王素芝(외）
  24. 疎風活血湯加味가 류마토이드 關節炎患者에서 分離한 synoviocytes에 대한 免疫反應과 collagen으로 誘發된 생쥐의 關節炎 抑制에 미치는 影響 郭重文
  25. 류마토이드 關節炎患者synoviocytes에 대한 鷄血藤의 免疫反應 서애경
  26. J. Immuno-logical method. v.208 Optimi- zation of the sulforhodaｍine B (SRB) Colormetric assay Papazissi, K.；geroｍichalos. D.；Dimitriadis, K.；Kortssaris, H. https://doi.org/10.1016/S0022-1759(97)00137-3
  27. J. Clin. Microbiol. v.38 Quantification of fungal DNA by using fluorescence resonance energy transfer and the Light Cycler system. Loeffler, J.；N. Henke；H.　Hebart, D.　Schmidt； L.　Hagmeyer, U. Schumacher；H. Einsele.
  28. Rheumatology (Oxford). v.39 no.Suppl 1 New and future drug therapies for rheumatoid arthritis. Simon LS；Yocum D. https://doi.org/10.1093/oxfordjournals.rheumatology.a031493
  29. Rheuma-tology (Oxford). v.39 no.Suppl 1 Current treatment paradigms in rheumatoid arthritis. Fries JF. https://doi.org/10.1093/oxfordjournals.rheumatology.a031492
  30. 醫學心悟　　 程國彭　
  31. 諸病源候論　 巢元方　
  32. 景岳全書　 張介賓　
  33. 外臺秘要方　 王燾　
  34. 金櫃要略放論　 張仲景　
  35. 三因方 v.3 陳無擇　
  36. 鍼灸刺戟 및 疎風活血湯加味方 投與가 류마티스成 關節炎 患者의 血液에 미치는 影響 안선준　
  37. J Rheumatol. v.29 no.Suppl 65 The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. Bingham CO 3rd.
  38. Ann Rheum Dis. v.61 no.10 Synovial macrophage-osteoclast differentiation in inflammatory arthritis. Danks L；Sabokbar A；Gundle R；Athanasou NA. https://doi.org/10.1136/ard.61.10.916
  39. Inflamm Res. v.50 no.2 An investigation of cell proliferation and soluble mediators induced by interleukin １beta in human synovial fibroblasts: comparative response in osteoarthritis and rheumatoid arthritis. Inoue H；Takamori M；Nagata N；Nishikawa T；Oda H； Yamamoto S；Koshihara Y. https://doi.org/10.1007/s000110050726
  40. Przegl Lek. v.59 no.2 Cytokines and their antagonists in the treatment of rheumatoid arthritis Klimiuk PA；Sierakowski S.
  41. Curr Pharm Des. v.8 no.24 Structure-based Design of Mimetics for Granulocyte-macrophage Colony Stimulating Factor (GM-CSF). Monfardini C；Canziani G；Plugariu C；Kieber Emmons T； Godillot AP；Kwah J；Bajgier J；Chaiken I；Williams WV. https://doi.org/10.2174/1381612023393198
  42. TheJournal of Biological Chemistry v.273 no.38 Regulation of Interleukin-1＜ＴＥＸ＞＄｛￦ｂｅｔａ｝＄＜／ＴＥＸ＞-induced Interleukin-6 gene Expression in Human Fibroblast-like Synoviocytes by p38 Mitogen-activated Protein Kinase, U.S.A. Keiji Miyazawa
  43. Bone. Feb v.30 no.2 Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Romas E；Gillespie MT；Martin TJ. https://doi.org/10.1016/S8756-3282(01)00682-2
  44. Transplant Proc. Dec v.30 no.8 Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases. Feldman M；Taylor P；Paleolog E；Brennan FM；Maini RN. https://doi.org/10.1016/S0041-1345(98)01365-7
  45. FEMS Immunol Med Microbiol. v.15 no.34(3) Cyclooxygenase 2 activity modulates the severity of murine Lyme arthritis. Anguita J；Samanta S；Ananthanarayanan SK；Revilla B；Geba GP；Barthold SW；Fikrig E.
  46. J Pain Symptom Manage. v.24 no.1 Suppl Pharmacoeconoｍics of coxib therapy. Cantor SB. https://doi.org/10.1016/S0885-3924(02)00412-8
  47. Expert Opin Pharma-cother. v.3 no.10 Meloxicam. Fleischmann R；Iqbal I；Slobodin G. https://doi.org/10.1517/14656566.3.10.1501
  48. Life Sci. v.12 no.68(8) Effects of nitric oxide on matrix metalloproteinase-2 production by rheumatoid synovial cells. Hirai Y；Migita K；Honda S；Ueki Y；Yamasaki S；Urayama S； Kamachi M；Kawakami A；Ida H；Kita M；Fukuda T；Shibatomi K；Kawabe Y；Aoyagi T；Eguchi K.
  49. Arthritis Rheum. v.41 no.12 Enhanced and coordinated In vitro expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Melchiorri C；Meliconi R；Frizziero L；Silvestri T；Pulsatelli L； Mazzetti I；Borzi RM；Uguccioni M；Facchini A. https://doi.org/10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.0.CO;2-O
  50. Immunology. v.103 no.3 Nitric oxide and bone. Van't Hof RJ;Ralston SH. https://doi.org/10.1046/j.1365-2567.2001.01261.x
  51. Gen Physiol Biophys. v.18 Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Bauerova K；Bezek A.
  52. J Neurosci. v.1 no.18(17) Nitric oxide signaling in pain and nocicepter sensitization in the rat. Aley KO；McCarter G；Levine JD.
  53. Infect Immun. v.70 no.8 Roles of p38 mitogen-activated protein proinflammatory cytokine mRNA expression by human peripheral blood leukocytes. monocytes, and neutrophils in response to Anaplasma phagocytophila. Kim HY;Rikihisa Y. https://doi.org/10.1128/IAI.70.8.4132-4141.2002
  54. Am J Physiol Lung Cell Mol Physiol. v.281 no.6 Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Hozumi A;Nishimura Y;Nishimura T;Kotani Y;Yokoyama M. https://doi.org/10.1152/ajplung.2001.281.6.L1444
  55. J Bone Miner Res. v.15 no.12 Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells. Palcy S;Bolival I;Goltzman D. https://doi.org/10.1359/jbmr.2000.15.12.2352
  56. Free Radic Biol Med. v.22 no.1-2 Immunogenicity of DNA damaged by reactive oxygen species-implications for anti-DNA antibodies in lupus. Cook MS;Mistry N;Wood C;Herbert KE;Lunec J. https://doi.org/10.1016/S0891-5849(96)00283-3
  57. Biochem Mol Biol Int. v.47 no.5 Human anti-DNA autoantibodies and induced antibodies against ROS-modified-DNA show similar antigenic binding characteristics. Alam K;Ail R.